With 37.87 million shares changed hands, the volume of the stock remained heavier than its average volume of 17.01 million shares. During the session, the Capital Markets company that operates in wider Financial sector, reached to the highest price of $14.29 whereas the lowest price it dropped to was $13.09. The 52-week range on IREN shows that it touched its highest point at $15.92 and its lowest point at $5.12 during that stretch. It currently has a 1-year price target of $18.57. Beta for the stock currently stands at 3.94.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IREN was up-trending over the past week, with a rise of 33.72%, but this was up by 58.01% over a month. Three-month performance surged to 116.72% while six-month performance rose 24.44%. The stock gained 42.57% in the past year, while it has gained 7.78% so far this year. A look at the trailing 12-month EPS for IREN yields -0.23 with Next year EPS estimates of 0.86. For the next quarter, that number is 0.09. This implies an EPS growth rate of 93.00% for this year and 4324.93% for next year.
Float and Shares Shorts:
At present, 240.97 million IREN shares are outstanding with a float of 227.74 million shares on hand for trading. On 2025-06-13, short shares totaled 28.68 million, which was 1185.99996 higher than short shares on 1747267200. In addition to Mr. William Roberts as the firm’s Co-Founder, Co-CEO & Director, Mr. Daniel Roberts serves as its Co-Founder, Co-CEO & Director.
Institutional Ownership:
Through their ownership of 0.59392 of IREN’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, IREN reported revenue of $144823000.0 and operating income of $24622000.0. The EBITDA in the recently reported quarter was $77271000.0 and diluted EPS was $0.0011.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for IREN since 7 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With IREN analysts setting a high price target of 24.0 and a low target of 12.0, the average target price over the next 12 months is 18.70455. Based on these targets, IREN could surge 71.43% to reach the target high and fall by -14.29% to reach the target low. Reaching the average price target will result in a growth of 33.6% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.00439833 being high and -$0.00125667 being low. For IREN, this leads to a yearly average estimate of $0.001885.
